Delivery Order SPE2DR25D7062-SPE2DR26FW9BB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Epidiolex 100 mg/ml solution in 100 ml packs, with a ceiling value of $1,682.50 and an ultimate completion date of October 9, 2025. This competitively awarded, firm fixed-price delivery order was placed without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved...
- The Defense Logistics Agency awarded a $1,280.92 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, with an ultimate completion date of October 6, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol medication used primarily for...
- The Defense Logistics Agency awarded a $3,720.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 milliliters of Epidiolex 100 mg/ml solution on November 5, 2025, with completion targeted for November 28, 2025. This is a non-set-aside delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at the company's...
- The Defense Logistics Agency awarded a $1,682.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for Epidiolex 100 mg/ml solution in a 100 ml pack. This non-set-aside competitive award is scheduled for completion by September 10, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Epidiolex is a cannabidiol-based pharmaceutical used primarily for seizure management, reflecting the federal government's medical supply procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for supply of Epidiolex 100 mg/ml solution in 60 ml packs, with a ceiling value of $1,349.88 and an ultimate completion date of January 2, 2026. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,523.75 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs on September 12, 2025, with an ultimate completion date of October 3, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a $8,412.50 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Epidiolex 100 mg/ml solution in 100 ml packs, with completion targeted for September 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,365.00 to AmerisourceBergen Drug Corp for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. This firm fixed-price delivery order, awarded on August 29, 2025, is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a non-set-aside competitive award, demonstrating the vendor's capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Epidiolex 100 mg/ml solution in 100ml packs, with a ceiling value of $1,682.50 and a firm fixed price structure. This delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.04 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/mL solution in 100 mL packs, with an ultimate completion date of November 20, 2025. This non-competitive delivery order represents a firm fixed price transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. The...
- SPE2DR25D7062Indefinite Delivery Contract
- SPE2DR25D7062-SPE2DR26FW9BBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,349.90 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml oral solution on December 10, 2025, with completion expected by December 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively through open procurement. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. Epidiolex is a cannabidiol-based therapeutic used primarily for seizure disorders, reflecting the Defense Logistics Agency's medical supply procurement for military healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's consistent success in federal pharmaceutical procurement reflects its capability to meet stringent federal contracting requirements through competitive award processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/9/25 |